Clinical Trials Browser

INDUSTRY × silmitasertib × Dermatologic × Clear all

NCT03897036 2025-05-20

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Phase 1 Completed

25 enrolled 9 charts

Carcinoma, Basal Cell